Renaissance Technologies’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.38M | Sell |
247,060
-66,392
| -21% | -$1.72M | 0.01% | 1363 |
|
|
2025
Q1 | $3.2M | Buy |
313,452
+52,733
| +20% | +$538K | ﹤0.01% | 1707 |
|
|
2024
Q4 | $3.64M | Buy |
260,719
+38,877
| +18% | +$542K | 0.01% | 1646 |
|
|
2024
Q3 | $4.33M | Buy |
221,842
+920
| +0.4% | +$17.9K | 0.01% | 1532 |
|
|
2024
Q2 | $4.11M | Sell |
220,922
-87,123
| -28% | -$1.62M | 0.01% | 1434 |
|
|
2024
Q1 | $4.32M | Sell |
308,045
-46,987
| -13% | -$658K | 0.01% | 1506 |
|
|
2023
Q4 | $3.01M | Buy |
355,032
+121,253
| +52% | +$1.03M | ﹤0.01% | 1690 |
|
|
2023
Q3 | $2.09M | Sell |
233,779
-39,000
| -14% | -$348K | ﹤0.01% | 1833 |
|
|
2023
Q2 | $2.35M | Buy |
272,779
+72,533
| +36% | +$626K | ﹤0.01% | 1890 |
|
|
2023
Q1 | $2.11M | Buy |
200,246
+192,439
| +2,465% | +$2.03M | ﹤0.01% | 1992 |
|
|
2022
Q4 | $265K | Buy |
+7,807
| New | +$265K | ﹤0.01% | 3282 |
|
|
2019
Q3 | – | Sell |
-21,803
| Closed | -$11.6M | – | 3610 |
|
|
2019
Q2 | $11.6M | Buy |
21,803
+8,106
| +59% | +$4.33M | 0.01% | 1302 |
|
|
2019
Q1 | $6.9M | Sell |
13,697
-13,100
| -49% | -$6.6M | 0.01% | 1604 |
|
|
2018
Q4 | $13.2M | Buy |
26,797
+22,207
| +484% | +$10.9M | 0.01% | 1149 |
|
|
2018
Q3 | $4.2M | Buy |
4,590
+2,667
| +139% | +$2.44M | ﹤0.01% | 1914 |
|
|
2018
Q2 | $1.41M | Buy |
+1,923
| New | +$1.41M | ﹤0.01% | 2450 |
|
|
2018
Q1 | – | Sell |
-6,123
| Closed | -$5.49M | – | 3504 |
|
|
2017
Q4 | $5.49M | Buy |
+6,123
| New | +$5.49M | 0.01% | 1747 |
|
|
2015
Q2 | – | Sell |
-37,870
| Closed | -$6.25M | – | 3315 |
|
|
2015
Q1 | $6.25M | Buy |
37,870
+9,060
| +31% | +$1.5M | 0.01% | 1222 |
|
|
2014
Q4 | $6.7M | Buy |
+28,810
| New | +$6.7M | 0.02% | 1106 |
|